JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) was the target of a significant decline in short interest in the month of July. As of July 15th, there was short interest totaling 1,905 shares, a decline of 92.8% from the June 30th total of 26,434 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 3,863 shares, the short-interest ratio is currently 0.5 days.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the business. JPMorgan Chase & Co. bought a new stake in shares of JLens 500 Jewish Advocacy U.S. ETF during the third quarter valued at about $25,000. Bank of New York Mellon Corp lifted its holdings in JLens 500 Jewish Advocacy U.S. ETF by 66.7% in the first quarter. Bank of New York Mellon Corp now owns 71,189 shares of the company’s stock worth $1,946,000 after purchasing an additional 28,496 shares during the period. Finally, Captrust Financial Advisors bought a new position in JLens 500 Jewish Advocacy U.S. ETF in the 2nd quarter valued at about $6,038,000.
JLens 500 Jewish Advocacy U.S. ETF Price Performance
TOV stock traded up $0.01 on Friday, reaching $31.05. The company’s stock had a trading volume of 330 shares, compared to its average volume of 11,932. JLens 500 Jewish Advocacy U.S. ETF has a 52 week low of $26.19 and a 52 week high of $32.04. The company has a market capitalization of $261.13 million, a P/E ratio of 25.69 and a beta of 1.03. The firm has a fifty day moving average of $31.42 and a two-hundred day moving average of $29.82.
JLens 500 Jewish Advocacy U.S. ETF Company Profile
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
See Also
- Five stocks we like better than JLens 500 Jewish Advocacy U.S. ETF
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
